FloBio Receives FDA’s Breakthrough Device Designation for Bleeding Risk Diagnostic Test
Legacy MEDSearch
OCTOBER 17, 2023
Food and Drug Administration has granted Breakthrough Device Designation for its rapid bleeding risk diagnostic test. Today millions of Americans use DOACs, a highly effective and widely used drug for managing atrial fibrillation and deep vein thrombosis. DOACs can elevate bleeding risk and complicate emergency care.
Let's personalize your content